Bio-Techne (TECH) EBIT (2009 - 2026)

Bio-Techne's EBIT history runs 18 years deep, the most recent figure standing at $75.5 million for Q1 2026.

• In Q1 2026, EBIT rose 95.04% year-over-year to $75.5 million; the TTM figure through Mar 2026 stood at $153.8 million (down 10.58% YoY), while the FY2025 annual figure was $102.3 million, down 50.53% from the prior year.
• EBIT was $75.5 million for Q1 2026 at Bio-Techne, up from $54.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $94.5 million in Q2 2023 to a low of -$23.9 million in Q2 2025.
• Historically, EBIT has averaged $56.3 million across 5 years, with a median of $55.9 million in 2023.
• The sharpest annual moves came in 2025 and 2026: EBIT tumbled 152.07% in 2025, then surged 95.04% in 2026.
• A 5-year view of EBIT shows it stood at $67.9 million in 2022, then plunged by 44.02% to $38.0 million in 2023, then grew by 24.77% to $47.4 million in 2024, then advanced by 14.85% to $54.5 million in 2025, then surged by 38.62% to $75.5 million in 2026.
• The last three EBIT figures came in at $75.5 million (Q1 2026), $54.5 million (Q4 2025), and $47.7 million (Q3 2025), per Business Quant data.